In gastric cancer, Cx30 was proposed as a potential marker for an intestinal-type cancer phenotype, and the negative expression of Cx30 correlates with a more advanced T grade ( < 0.0001), N grade (0.0123) and tumour stage (0.0014) [74]. Here, GJB6 is linked to neoplasm.